Old drug, new trick: proton pump inhibitors find new purpose in cancer care
Old drug, new trick: proton pump inhibitors find new purpose in cancer care |
|
https://doi.org/10.18632/oncotarget.28053
Natalie A. Ridge,
Mohit Shiv Agarwal,
and Mohamad Hassan Fakhreddine
|
| 1861-1862 |
Novel insights into the molecular mechanisms underlying risk of colorectal cancer from smoking and red/processed meat carcinogens by modeling exposure in normal colon organoids
Novel insights into the molecular mechanisms underlying risk of colorectal cancer from smoking and red/processed meat carcinogens by modeling exposure in normal colon organoids |
|
https://doi.org/10.18632/oncotarget.28058
Matthew Devall,
Christopher H. Dampier,
Stephen Eaton,
Mourad W. Ali,
Virginia Díez-Obrero,
Ferran Moratalla-Navarro,
Jennifer Bryant,
Lucas T. Jennelle,
Victor Moreno,
Steven M. Powell,
Ulrike Peters,
and Graham Casey
|
| 1863-1877 |
Nanoparticle T cell engagers for the treatment of acute myeloid leukemia
Nanoparticle T cell engagers for the treatment of acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.28054
Kinan Alhallak,
Jennifer Sun,
Barbara Muz,
Amanda Jeske,
Jessica Yavner,
Hannah Bash,
Chaelee Park,
Berit Lubben,
Ola Adebayo,
Samuel Achilefu,
John F. DiPersio,
and Abdel Kareem Azab
|
| 1878-1885 |
Altered glucuronidation deregulates androgen dependent response profiles and signifies castration resistance in prostate cancer
Altered glucuronidation deregulates androgen dependent response profiles and signifies castration resistance in prostate cancer |
|
https://doi.org/10.18632/oncotarget.28059
Brenna M. Zimmer,
Michelle E. Howell,
Linlin Ma,
Jeffrey R. Enders,
Danielle Lehman,
Eva Corey,
Joseph J. Barycki,
and Melanie A. Simpson
|
| 1886-1902 |
The antitumoral effects of chemerin are independent from leukocyte recruitment and mediated by inhibition of neoangiogenesis
The antitumoral effects of chemerin are independent from leukocyte recruitment and mediated by inhibition of neoangiogenesis |
|
https://doi.org/10.18632/oncotarget.28056
Ingrid Dubois-Vedrenne,
Diana Al Delbany,
Olivier De Henau,
Virginie Robert,
Maxime Vernimmen,
Francina Langa,
Anne Lefort,
Frédérick Libert,
Valérie Wittamer,
and Marc Parmentier
|
| 1903-1919 |
Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer
Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.28068
Bruna Cândido Guido,
Douglas Cardoso Brandão,
Ana Luisa Augusto Barbosa,
Monique Jacob Xavier Vianna,
Lucas Faro,
Luciana Machado Ramos,
Fabíola Nihi,
Márcio Botelho de Castro,
Brenno A.D. Neto,
José Raimundo Corrêa,
and Sônia Nair Báo
|
| 1920-1936 |
High expression of Myosin 1g in pediatric acute lymphoblastic leukemia
High expression of Myosin 1g in pediatric acute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.28055
Laura A. Estrada-Abreo,
Leonor Rodríguez-Cruz,
Yanelly Garfias-Gómez,
Janeth E. Araujo-Cardenas,
Gabriela Antonio-Andrés,
Alfonso R. Salgado-Aguayo,
Darío Orozco-Ruiz,
José Refugio Torres-Nava,
Juan D. Díaz-Valencia,
Sara Huerta-Yépez,
and Genaro Patiño-López
|
| 1937-1945 |
Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition
Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition |
|
https://doi.org/10.18632/oncotarget.28062
Marcel Kemper,
Georg Evers,
Arik Bernard Schulze,
Jan Sperveslage,
Christoph Schülke,
Georg Lenz,
Thomas Herold,
Wolfgang Hartmann,
Hans-Ulrich Schildhaus,
and Annalen Bleckmann
|
| 1946-1952 |
Towards precision oncology in angiosarcomas using next generation “omic” technologies
Towards precision oncology in angiosarcomas using next generation “omic” technologies |
|
https://doi.org/10.18632/oncotarget.27996
Grace Fangmin Tan,
and Jason Yongsheng Chan
|
| 1953-1955 |
Targeting AP-1 transcription factors by CRISPR in the prostate
Targeting AP-1 transcription factors by CRISPR in the prostate |
|
https://doi.org/10.18632/oncotarget.27997
Maria Riedel,
Huiqiang Cai,
Iben C. Stoltze,
Mikkel H. Vendelbo,
Erwin F. Wagner,
Latifa Bakiri,
and Martin K. Thomsen
|
| 1956-1961 |
The role of dynamic phenotypes in cancer
The role of dynamic phenotypes in cancer |
|
https://doi.org/10.18632/oncotarget.28006
Luana S. Lenz,
and Guido Lenz
|
| 1962-1965 |
Correction: Cycling hypoxia affects cell invasion and proliferation through direct regulation of claudin1 / claudin7 expression, and indirect regulation of p18 through claudin7
Correction: Cycling hypoxia affects cell invasion and proliferation through direct regulation of claudin1 / claudin7 expression, and indirect regulation of p18 through claudin7 |
|
https://doi.org/10.18632/oncotarget.27385
Hong Liu,
Feifei Jiang,
Xinshan Jia,
Jing Lan,
Hao Guo,
Erran Li,
Aihui Yan,
and Yan Wang
|
| 1966-1969 |
